Zaltrius' solutions for COVID-19 testing, research, and vaccine development.

ザルトリウス・ジャパン

Zaltrius has collaborated with biopharmaceutical companies as a supplier in the development and manufacturing of vaccines in response to outbreaks and pandemics of infectious diseases such as Ebola, Zika, and H1N1 over the past decade. Zaltrius's experience and solution portfolio will support customers at all stages of vaccine development against the novel coronavirus SARS-CoV-2 outbreak, from discovery to testing and large-scale manufacturing. We provide solutions to help you manage various risks in vaccine development and manufacturing while maintaining speed, quality, and flexibility in emergency situations.

Date and time
Capital
Entry fee

Related product information

"Newly released 5ml tip with filter" with air gap to prevent contamination.
The unique Safety Space (air gap) within the tip reduces the risk of contact between the pipette sample and the filter.

The Sartorius Safety Space filter chip is DNase, RNase, Endotoxin Free, and Human DNA free. *Certificates can be downloaded from the web for each lot. *For more details, please refer to the PDF materials or feel free to contact us. We are also accepting requests for samples and the Pipette Academy.